Figure 1From: Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo studyUnsupervised cluster analysis of apoptotic gene expression modification upon ATO and Ascorbic Acid treatment. Figure depicts -ΔΔCt of the “test patient” (lane #6) versus the remaining ones.Back to article page